Supplemental magnetic resonance imaging plus mammography compared with magnetic resonance imaging or mammography by extent of breast density
JNCI: Journal of the National Cancer Institute · 08.02.2024 · 116 (2) · 249-257
DOI: 10.1093/jnci/djad201 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, online erschienen am 25.09.2023. Verfasst von Karla Kerlikowske und 10 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Medicine and Epidemiology and Biostatistics, University of California, San Francisco, CA, USA. Hauptthemen laut MEDLINE: Breast Density, Breast Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Patient-Centered Outcomes Research Institute, AHRQ HHS.
Abstract (Originalsprache)
Background
Examining screening outcomes by breast density for breast magnetic resonance imaging (MRI) with or without mammography could inform discussions about supplemental MRI in women with dense breasts.
Methods
We evaluated 52 237 women aged 40-79 years who underwent 2611 screening MRIs alone and 6518 supplemental MRI plus mammography pairs propensity score–matched to 65 810 screening mammograms. Rates per 1000 examinations of interval, advanced, and screen-detected early stage invasive cancers and false-positive recall and biopsy recommendation were estimated by breast density (nondense = almost entirely fatty or scattered fibroglandular densities; dense = heterogeneously/extremely dense) adjusting for registry, examination year, age, race and ethnicity, family history of breast cancer, and prior breast biopsy.
Results
Screen-detected early stage cancer rates were statistically higher for MRI plus mammography vs mammography for nondense (9.3 vs 2.9; difference = 6.4, 95% confidence interval [CI] = 2.5 to 10.3) and dense (7.5 vs 3.5; difference = 4.0, 95% CI = 1.4 to 6.7) breasts and for MRI vs MRI plus mammography for dense breasts (19.2 vs 7.5; difference = 11.7, 95% CI = 4.6 to 18.8). Interval rates were not statistically different for MRI plus mammography vs mammography for nondense (0.8 vs 0.5; difference = 0.4, 95% CI = -0.8 to 1.6) or dense breasts (1.5 vs 1.4; difference = 0.0, 95% CI = -1.2 to 1.3), nor were advanced cancer rates. Interval rates were not statistically different for MRI vs MRI plus mammography for nondense (2.6 vs 0.8; difference = 1.8 (95% CI = -2.0 to 5.5) or dense breasts (0.6 vs 1.5; difference = -0.9, 95% CI = -2.5 to 0.7), nor were advanced cancer rates. False-positive recall and biopsy recommendation rates were statistically higher for MRI groups than mammography alone.
Conclusion
MRI screening with or without mammography increased rates of screen-detected early stage cancer and false-positives for women with dense breasts without a concomitant decrease in advanced or interval cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Departments of Medicine and Epidemiology and Biostatistics, University of California, San Francisco, CA, USA.
- General Internal Medicine Section, Department of Veterans Affairs, University of California, San Francisco, CA, USA.
- Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, WA, USA.
- Departments of Surgery and Radiology, University of Vermont, Burlington, VT, USA.
- Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.
- Department of Population Health Sciences, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT, USA.
ORCID-Profile: Karla Kerlikowske
Förderung
- NCI NIH HHS
- Patient-Centered Outcomes Research Institute
- AHRQ HHS
- Breast Cancer Surveillance Consortium
- National Cancer Institute
- Agency for Health Research and Quality
- University of Vermont Cancer Center
- Lake Champlain Cancer Research Organization
Zitieren
APA
Kerlikowske, K., Zhu, W., Su, Y. R., Sprague, B. L., Stout, N. K., Onega, T., O'Meara, E. S., Henderson, L. M., Tosteson, A. N. A., Wernli, K., & Miglioretti, D. L. (2024). Supplemental magnetic resonance imaging plus mammography compared with magnetic resonance imaging or mammography by extent of breast density. JNCI: Journal of the National Cancer Institute, 116(2), 249-257. https://doi.org/10.1093/jnci/djad201
Vancouver
Kerlikowske K, Zhu W, Su YR, Sprague BL, Stout NK, Onega T, et al. Supplemental magnetic resonance imaging plus mammography compared with magnetic resonance imaging or mammography by extent of breast density. JNCI: Journal of the National Cancer Institute. 2024;116(2):249-257. doi:10.1093/jnci/djad201
BibTeX
@article{Kerlikowske2024,
author = {Kerlikowske, Karla and Zhu, Weiwei and Su, Yu-Ru and Sprague, Brian L and Stout, Natasha K and Onega, Tracy and O'Meara, Ellen S and Henderson, Louise M and Tosteson, Anna N A and Wernli, Karen and Miglioretti, Diana L},
title = {Supplemental magnetic resonance imaging plus mammography compared with magnetic resonance imaging or mammography by extent of breast density},
journal = {JNCI: Journal of the National Cancer Institute},
year = {2024},
volume = {116},
number = {2},
pages = {249--257},
doi = {10.1093/jnci/djad201}
}
EUVIMED